<DOC>
	<DOCNO>NCT01266096</DOCNO>
	<brief_summary>Current test detect cancer , include CAT scan MRI scan , limited . PET scan use special dye inject vein well localize possible cancer . The investigator develop new particle carry radioactive dye specific area tumor . When use PET scan radioactive dye view area possible disease . This particle study mice safe . The particle treat cancer image information find study use treatment . The information collect may use guide design future study detect and/or treat tumor .</brief_summary>
	<brief_title>PET Imaging Patients With Melanoma Malignant Brain Tumors Using 124I-labeled cRGDY Silica Nanomolecular Particle Tracer : A Microdosing Study</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>18 year age old Histologically confirm diagnosis melanoma malignant brain tumor MSKCC Newlydiagnosed recurrent ( local , regional , metastatic ) metastatic melanoma malignant brain tumor patient Residual clinically radiographically evident tumor , include primary cutaneous mucosal melanoma malignant brain tumor Prior radiation therapy , chemotherapy , surgery patient require flap reconstruction head neck region . Newly diagnose patient previous excisional biopsy . Normal baseline cardiac function base upon preoperative evaluation At discretion physician ANC &gt; 1000/mcl platelet &gt; 100,000/mcl . At discretion physician Bilirubin level &lt; 2.0 mg/dl absence history Gilbert 's disease ( pattern consistent Gilbert 's ) . If patient history malignancy melanoma malignant brain tumor must diseasefree ( exclude primary cancer metastatic patient ) â‰¥ 5 year time enrollment . All patient childbearing childcreating age must use acceptable form birth control Women premenopausal must negative serum pregnancy test Abnormal thyroid function , untreated clinical diagnosis hypothyroidism , hyperthyroidism , thyroid disease Known pregnancy breastfeeding . Medical illness unrelated tumor opinion attend physician principal investigator preclude administration tracer . This include patient uncontrolled infection , chronic renal insufficiency , myocardial infarction within past 6 month , unstable angina , cardiac arrhythmia chronic atrial fibrillation chronic active persistent hepatitis , New York Heart Association Classification III IV heart disease . History malignancy ( exclude primary cancer metastatic patient ) melanoma malignant brain tumor diseasefree interval &lt; 5 year . Allergic reaction iodinecontaining contrast material Weight great 400lb weight limit PET scanner Claustrophobia Inability lie scanner 30 minute</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>124I-cRGDY-PEG-dots</keyword>
	<keyword>Pet scan</keyword>
	<keyword>10-155</keyword>
	<keyword>melanoma</keyword>
	<keyword>brain</keyword>
</DOC>